Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.
Advertisement
International news in seven languages
Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.

Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.